| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.043 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |